COVID-19 vaccine hesitancy in Zambia: a glimpse at the possible challenges ahead for COVID-19 vaccination rollout in sub-Saharan Africa

Hum Vaccin Immunother. 2022 Dec 31;18(1):1-6. doi: 10.1080/21645515.2021.1948784. Epub 2021 Jul 6.

Abstract

With unprecedented speed, multiple vaccines against SARS-CoV-2 are available 1 year after the COVID-19 pandemic was first identified. As we push to achieve global control through these new vaccines, old challenges present themselves, including cold-chain storage, the logistics of mass vaccination, and vaccine hesitancy. Understanding how much hesitancy toward COVID-19 vaccines might occur and what factors may be driving these concerns can improve the ability of public health workers and communicators to maximize vaccine uptake. We nested a survey within a measles-rubella mass vaccination campaign in Zambia in November 2020 and asked about sentiments and beliefs toward COVID-19 and COVID-19 vaccines. Among parents bringing their children to receive a measles-rubella vaccine, we found high acceptability of COVID-19 vaccination of their children, but substantial uncertainty and hesitancy about receiving the vaccine themselves. COVID-19 vaccination hesitancy was correlated with beliefs around COVID-19 severity and risk, as well as vaccine safety and effectiveness.

Keywords: COVID-19; Zambia; vaccine; vaccine acceptance; vaccine hesitancy; vaccine safety.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19 Vaccines
  • COVID-19* / prevention & control
  • Child
  • Humans
  • Mass Vaccination
  • Measles Vaccine
  • Pandemics
  • SARS-CoV-2
  • Vaccination
  • Vaccination Hesitancy
  • Vaccines*
  • Zambia / epidemiology

Substances

  • COVID-19 Vaccines
  • Measles Vaccine
  • Vaccines

Grants and funding

This serosurvey was supported by the Strengthening Immunization Systems through Serosurveillance grant (Grant number 1094816) from The Bill & Melinda Gates Foundation to the International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health.